|
|
|
Insider
Information: |
Aberman Michael S |
Relationship: |
SVP Strategy Investor ... |
City: |
Tarrytown |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
4,693 |
|
Indirect Shares
|
12,253 |
|
|
Direct
Value |
$4,609,887 |
|
|
Indirect Value
|
$12,035,999 |
|
|
Total
Shares |
16,946 |
|
|
Total
Value |
$16,645,886 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regeneron Pharmaceuticals Inc |
REGN |
SVP Strategy Investor ... |
2017-06-22 |
4,693 |
2017-06-22 |
12,253 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
45 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
REGN |
Regeneron Pharmaceuticals... |
VP, Strat and Invest Relations |
|
2010-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2012-05-24 |
4 |
OE |
$24.00 |
$12,000 |
D/D |
500 |
10,500 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2012-12-18 |
4 |
OE |
$24.00 |
$28,800 |
D/D |
1,200 |
11,700 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2014-08-22 |
4 |
OE |
$24.00 |
$72,000 |
D/D |
3,000 |
18,600 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2013-06-17 |
4 |
OE |
$24.00 |
$93,600 |
D/D |
3,900 |
15,600 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
|
2015-12-17 |
4 |
OE |
$24.00 |
$96,000 |
D/D |
4,000 |
16,498 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2011-09-02 |
4 |
OE |
$24.00 |
$99,984 |
D/D |
4,166 |
14,166 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
|
2017-06-21 |
4 |
OE |
$30.63 |
$137,835 |
D/D |
4,500 |
9,193 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
|
2015-02-13 |
4 |
OE |
$24.00 |
$180,000 |
D/D |
7,500 |
26,100 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2011-09-06 |
4 |
OE |
$24.00 |
$200,016 |
D/D |
8,334 |
18,334 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2012-11-29 |
4 |
OE |
$24.00 |
$200,016 |
D/D |
8,334 |
18,834 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2013-05-06 |
4 |
OE |
$24.00 |
$200,016 |
D/D |
8,334 |
13,300 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2012-12-10 |
4 |
OE |
$30.63 |
$229,725 |
D/D |
7,500 |
18,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2014-02-14 |
4 |
OE |
$30.63 |
$229,725 |
D/D |
7,500 |
23,100 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
|
2015-02-23 |
4 |
OE |
$30.63 |
$229,725 |
D/D |
7,500 |
26,100 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2011-09-07 |
4 |
AS |
$67.39 |
$235,256 |
D/D |
(3,377) |
10,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2011-09-02 |
4 |
AS |
$64.00 |
$266,624 |
D/D |
(4,166) |
10,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP Strategy Investor Relation |
|
2015-03-17 |
4 |
OE |
$24.00 |
$273,552 |
D/D |
11,398 |
29,998 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2012-04-30 |
4 |
OE |
$24.00 |
$300,000 |
D/D |
12,500 |
22,500 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2013-05-13 |
4 |
OE |
$24.00 |
$300,000 |
D/D |
12,500 |
24,200 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2011-09-06 |
4 |
D |
$65.76 |
$325,972 |
D/D |
(4,957) |
13,377 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2014-08-18 |
4 |
OE |
$52.03 |
$455,263 |
D/D |
8,750 |
24,350 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2012-12-11 |
4 |
AS |
$184.85 |
$623,268 |
D/D |
(3,368) |
10,500 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2012-11-30 |
4 |
AS |
$180.08 |
$705,228 |
D/D |
(3,904) |
10,500 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
VP Strategy and Investor Relat |
|
2012-12-10 |
4 |
D |
$182.68 |
$754,834 |
D/D |
(4,132) |
13,868 |
0 |
- |
|
45 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|